21 results about "Nucleic acid cleavage" patented technology

The application discloses a method for identifying a protospacer adjacent motif, and relates to the technical field of biology. The method uses the nucleic acid cutting activity of CRISP-Cas protein, detects the specificity of CRISP-Cas protein to different PAM sequences in vitro by using a DNA array with 256 PAM sequences, and can clearly show the recognition preference of CRISP-Cas protein to each PAM sequence. Meanwhile, the method is simple in steps, easy to operate, does not need sequencing, and short in detection time, and can be used as a general detection method for CRISP-Cas protein.

The present invention provides TtdAgo mutant proteins with room-temperature target nucleic acid cleavage activity and their applications, belonging to the field of programmable nuclease technology. Relative to the wild-type TtdAgo protein, the TtdAgo mutant proteins have mutations at amino acids 527 and / or 561 and / or 593 and / or 599. Compared to the wild-type TtdAgo protein, the TtdAgo mutant proteins provided by the present invention not only have significantly improved activity at room temperature but are also capable of cleaving target RNA, effectively expanding the scope of application of the pAgo protein.

The invention discloses a gene therapy nose drop for preventing and / or treating coronavirus as well as preparation and application of the gene therapy nose drop, and belongs to the technical field of biological medicines. The nose drop comprises a reagent A and a reagent B. The reagent A is a nano-gene therapy drug solution connecting a self-assembled composite nano-material carrier and a targeted nucleic acid cleavage system through a click reaction, and the cleavage system comprises endonuclease molecules and an hpDNA oligonucleotide probe set. The hpDNA probe can target a coronavirus N gene conserved sequence and a host cell CtslmRNA at the same time through stem-loop structural design, can cut virus RNA to inhibit replication of the virus RNA, and can block the activation process of virus spike protein; the reagent B is an inhalable preparation of an anti-inflammatory chemical drug, and the drug absorption efficiency is remarkably improved by regulating inflammatory reaction. The nose drop can efficiently prevent and treat coronavirus infection and respiratory tract complications caused by the coronavirus infection through a triple mechanism of'gene editing-host regulation-anti-inflammatory treatment 'in combination with the advantage of nasal local administration, and has the obvious characteristics of high bioavailability and low system toxicity.

Provided are: a nucleic acid cleavage enzyme which comprises a nuclease domain having a specific amino acid sequence and a nucleic acid binding domain; a use of the nucleic acid cleavage enzyme; a method for producing a variant of a eukaryotic cell, the method comprising deleting a centromere region of a genome on a chromosome in the eukaryotic cell; a use of the method; a vector or a DNA fragment for use in engineering of a gene of a eukaryotic organism, the vector or the DNA fragment including a telomeric repeat sequence; and a use of the vector or the DNA fragment.

This invention discloses a method and kit for rapid detection of deeply infected Aspergillus. The method involves mixing the sample to be tested with a nucleic acid cleavage extract and heating at 60–65°C for 8–20 min, followed by heating at 93–98°C for 5–10 min to obtain a DNA extract. This DNA extract is then added to a PCR premix containing a composition of deeply infected Aspergillus to prepare a PCR reaction solution. The PCR reaction solution is subjected to the following PCR amplification reactions: denaturation is performed at 90–100°C for 0–5 s, followed by annealing and extension at 50–70°C for 0–5 s, repeated 35–50 times. This method not only provides a specific primer and probe composition capable of distinguishing between Aspergillus flavus, Aspergillus niger, and Aspergillus fumigatus, but also enables rapid detection of the sample from nucleic acid extraction to nucleic acid amplification, saving detection time.

A tagmentation method uses binding agents and / or nucleic acid modification enzymes having hybridizable (e.g., complementary) oligonucleotides to recruit the modification enzymes to binding agents bound to their targets in chromatin. After nucleic acid modification, e.g., cleavage of nucleic acids near the binding site, and attachment of adaptors, such as amplification adaptors, tagged nucleic acids can be amplified and / or sequenced to aid in epigenetic mapping.

This invention belongs to the field of programmable nuclease technology, and particularly relates to a TcAgo protein mutant and its encoding gene, a nucleic acid cleavage reagent containing the mutant, and its applications. The amino acid sequence of the TcAgo protein mutant is selected from one of SEQ ID NO. 2-4. The TcAgo protein mutant provided by this invention has advantages such as improved low-temperature and medium-temperature performance, high room-temperature catalytic activity, wide temperature adaptability, broadened substrate spectrum, and high stability. It is beneficial for overcoming high-temperature dependence, adapting to in vivo and room-temperature physiological environments, and promoting the development of gene editing, molecular diagnostic technology, biosensing, and other fields towards in vivo applications and mild reactions. It solves the problem of insufficient activity and limited application of thermophilic pAgo proteins, including TcAgo, under mild conditions in existing technologies.

The application discloses a nucleic acid cleavage amplification device. The nucleic acid cleavage amplification device comprises a pushing device, a liquid storage device and a chip. The liquid storage device is internally provided with multiple cavities, the pushing device extends into the interior of the liquid storage device, and the pushing device is slidably connected with the liquid storage device below. One end of the liquid storage device is snap-connected with the upper portion of the pushing device, and the other end of the liquid storage device is snap-connected with the chip. The liquid storage device is connected with the chip through a liquid inlet channel. The chip comprises a chip body, a quantitative groove, a waste liquid groove and a positioning support column. Multiple quantitative grooves and waste liquid grooves are arranged, the quantitative grooves and the waste liquid grooves are arranged on the chip body, the quantitative grooves and the waste liquid grooves are connected with the liquid storage device through quantitative channels and waste liquid channels respectively, and the positioning support column is arranged on one side of the bottom of the chip body. The chip further comprises a buffer channel, one end of the buffer channel is connected with the quantitative channel, the other end of the buffer channel is connected with the quantitative groove, and the cross-sectional area of the buffer channel is smaller than that of the quantitative channel, so that the accuracy of nucleic acid detection is improved.

The present invention relates to novel compounds of formula (I) as defined herein, which are suitable for non-enzymatic cleavage of target nucleic acids. The invention also relates to pharmaceutical compositions comprising these compounds, and to the use of these compounds in, for example, epigenomic and epitranscriptome mapping, and in therapy, for example, antimicrobial and / or antiviral therapy.

The invention provides a plasmodium falciparum detection composition based on an RPA-PfAgo detection method, a kit, a detection method and application, and belongs to the technical field of gene detection. According to the invention, a nucleic acid isothermal amplification technology RPA and a PfAgo technology are combined, a novel visual rapid detection method is developed, the method is used for detecting plasmodium falciparum, and the high-specificity nucleic acid cutting capability of the gene editing enzyme PfAgo technology and the isothermal rapid amplification advantage of the nucleic acid isothermal amplification technology are fully fused. The detection method disclosed by the invention is strong in specificity and high in sensitivity, the detection sensitivity reaches the level of 1 * 10 < 2 > copies / mu L, and target nucleic acid with extremely low concentration can be detected; and the detection can be completed within 60 minutes, so that the detection efficiency is improved, the detection result is intuitive and readable, the detection system conforms to the development trend of rapid and field detection, a detection system suitable for a resource limited environment is developed, and the innovation and development of a nucleic acid detection technology are promoted.

The invention provides a PfAgo detection system for synchronously detecting staphylococcus aureus and escherichia coli, an RPA primer group, a kit and a method, and belongs to the technical field of pathogenic bacterium detection. The system comprises PfAgo protein, at least two fluorescent report probes respectively corresponding to staphylococcus aureus and escherichia coli, and at least two groups of specific guide DNA (deoxyribonucleic acid), namely guide gDNA. According to the invention, RPA isothermal amplification and PfAgo protein-mediated nucleic acid cleavage reaction are combined, so that high-specificity and high-sensitivity rapid detection of two pathogenic bacteria is realized. The method is short in detection time, easy and convenient to operate, free of complex instruments and suitable for on-site rapid screening and multiple detection of pathogenic bacteria in complex matrixes such as food and cosmetics.

The application discloses a double-potential ratio type ECL biosensor, preparation and application thereof in MRSA detection. The application utilizes aptamer to convert bacteria into nucleic acid signal output, utilizes multi-stage nucleic acid cutting to realize amplification of the nucleic acid signal, and utilizes a large number of trivalent iron active centers in a metal organic gel to activate a co-reaction in an electrochemical reaction, so that two-pole luminescent materials can better emit signals. The nucleic acid signal amplification and signal strength improvement can help the platform to detect low-concentration bacteria, improve the sensitivity of the platform, and realize more accurate detection results through mutual correction of two-stage signals, and realize high-speed detection of low-concentration MRSA in various real samples.

The invention relates to a nested PCR (Polymerase Chain Reaction) method and application, and a targeted detection library building method improved based on the nested PCR library building method. According to the method, the nucleic acid cleavage activity of USER enzyme is utilized, and Taq DNA polymerase or an enzyme with both DNA polymerization activity and 5 '-3' excision enzyme activity is combined, so that a primer removal method is established and is used for replacing a purification step between a first round of PCR and a second round of PCR, and the problem of cross contamination between samples caused by purification operation of nested PCR is successfully solved. Meanwhile, the method can effectively remove non-specific amplification products and improve the specificity of targeted amplification, the experimental process is simpler and more convenient, and the nested PCR method can be applied to a targeted library building platform and a sequencing platform.

The present invention provides a genome modification method and a genome modification kit that can efficiently modify two or more alleles and modify relatively large regions. [Solution] A genome modification method for modifying two or more alleles of a chromosome genome, comprising: (a) introducing the following (i) and (ii) into a cell containing the chromosome; (i) a genome modification system comprising a sequence-specific nucleic acid cleavage molecule that targets a target region of the chromosome genome, or a polynucleotide encoding the sequence-specific nucleic acid cleavage molecule; (ii) two or more selection marker donor DNAs having mutually different selection marker genes (the number of types of selection marker donor DNAs is equal to or greater than the number of alleles to be modified); and (b) selecting the cell based on all the selection marker genes possessed by the two or more selection marker donor DNAs.

The invention discloses TtdAgo mutants with target nucleic acid cleavage activity at low temperatures and use thereof. Compared to wild-type TtdAgo, the TtdAgo mutant comprises mutations at amino acid position 527 and / or position 561 and / or position 593 and / or position 599. Relative to wild-type TtdAgo, these TtdAgo mutants not only exhibit significantly enhanced activity at moderate to low temperatures but also enable cleavage of target RNA, thereby effectively expanding the applicability range of pAgo.

The invention relates to the technical field of molecular biology and biological detection, in particular to a concentration dependent type dual-mode nucleic acid cleavage system and a concentration dependent type dual-mode nucleic acid cleavage method for mesophilic Clostridium perfringens Argonaute protein. The system is based on the cleavage behavior difference of CpAgo protein under different target single-stranded DNA (ssDNA) concentrations. When the concentration of the target ssDNA is micromole or above, the CpAgo shows non-specific ssDNA cleavage activity independent of a guide chain, and has wide compatibility to the length, sequence and various chemical modifications of a substrate; when the concentration of the target ssDNA is nanomole or below, the cleavage behavior of the target ssDNA is converted into a specific mode which strictly depends on a complementary guide chain. The dual-mode mechanism of the CpAgo and the efficient non-specific cutting capacity of the CpAgo at normal temperature are verified through electrophoresis, fluorescence kinetic analysis and comparison experiments with other prokaryotic Ago proteins. The system can be used for rapidly degrading exogenous nucleic acid or realizing high-specificity nucleic acid detection, and has the advantages of single-enzyme dual-mode, concentration gating, strong substrate compatibility and the like.

The application discloses a nucleic acid lysis buffer for RPA-CRISPR / RspCas13d detection and application thereof, and belongs to the technical field of biology. The nucleic acid lysis buffer is composed of 8-12 mM pH8 Tris-HCl, 0.8-1.2 mM EDTA, 0.05-0.15% Triton X-100, 0.8-1.2 mM DTT, 0.4-0.6% betaine, 0.8-1.2 U / μL mouse ribonuclease inhibitor and 0.08-0.12 mg / mL BSA, can quickly lyse and release nucleic acid in a sample to be detected under room temperature conditions, and does not need to be heated or a commercial nucleic acid extraction kit. The application further provides a buffer composition for RPA-CRISPR / RspCas13d detection. When the nucleic acid lysis buffer is combined with the buffer composition, RPA amplification, T7 transcription and RspCas13d detection can be simultaneously carried out in a single reaction tube at 37 DEG C, and one-step detection is realized. The application provides a fast and device-independent diagnosis method for pathogens such as CDV, and is especially suitable for on-site monitoring of endangered animals such as giant pandas and instant detection in an environment with limited resources.

The invention discloses a PfAgo mutant with enhanced target nucleic acid cleavage activity and application thereof, the PfAgo mutant protein is a protein obtained by mutation of the following (1) or (2) on the basis of a wild type PfAgo protein with an amino acid sequence as shown in SEQ ID NO.1: (1) V142A, Y413C, K417R and I623F; and (2) on the basis of (1), the 623rd amino acid is further mutated into methionine. The PfAgo mutant protein provided by the invention realizes significant breakthrough in target nucleic acid cleavage activity and practical performance. According to the M2A4 obtained through random mutation screening, the nucleic acid cleavage activity and the protein expression quantity are greatly improved compared with those of a wild type, the key functional site-I623F mutation is determined through site-specific mutagenesis verification, the catalytic efficiency and the high salt tolerance are directly improved through I623F mutation, the protein expression quantity is remarkably optimized through Y413C mutation, the discovery reveals a PfAgo structure and function association mechanism, and the application prospect is broad. And a molecular target is provided for accurate transformation.

The present invention relates to a method for generating ssDNA guides from dsDNA using an Argonaute protein. Said guides may be useful in applications, like selectively reducing repetitive sequences in sequencing libraries using Argonaute proteins. The invention further relates to a method for cleaving a nucleic acid molecule, a method for reducing the number of nucleic acid molecules comprising a target sequence and a method for selectively enriching and / or sequencing nucleic acid molecules in a sample, like a DNA sequencing library.

The invention provides a magnetic control ratio fluorescent biosensor based on RPA-CRISPR / Cas12a as well as a preparation method and application of the magnetic control ratio fluorescent biosensor, and belongs to the technical field of fluorescent biosensors and pathogenic bacterium detection. The magnetic control ratio fluorescence biosensor comprises a fluorescence reference signal element, a fluorescence response signal element and a specific recognition element, according to the magnetic control ratio fluorescent biosensor, high-sensitivity and specific detection of staphylococcus aureus and salmonella is realized through the magnetic and fluorescent characteristics of the fluorescent reference signal element, the fluorescent characteristic of the fluorescent response signal element and the nucleic acid cleavage activity of Cas12a; the magnetic control ratio fluorescent biosensor has a built-in calibration function, can reduce interference brought by the environment and instruments, has good selectivity to staphylococcus aureus and salmonella, has good anti-interference performance to other bacteria, and can be used for rapid detection in the field of food safety.

The invention discloses an efficient single-base editing tool for streptomyces as well as a construction method and application of the efficient single-base editing tool. The core of the single base editing tool disclosed by the invention is a fusion protein consisting of rat cytosine deaminase (rAPOBEC1), TnpB protein (dTnpB) without nucleic acid cleavage activity and uracil glycosylase inhibitor (UGI), so that accurate single base editing of genes in streptomycete is efficiently realized under the condition that DNA double-strand breakage is not introduced; and converting the cytosine (C) into thymine (T). Compared with a gene editing technology which depends on DSB to introduce random mutation, the method disclosed by the invention has the advantages that gene editing with single base precision can be realized to realize gene mutation, or codons for coding specific amino acids are mutated into termination codons to fulfill the aim of inactivating target genes.